Smart algorithm aims to tailor blood thinner use after stents
NCT ID NCT05732701
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a risk-score algorithm can safely personalize how long patients take dual antiplatelet therapy (two blood thinners) after getting a heart stent. About 2,788 participants will be assigned to either algorithm-guided or standard treatment duration. The goal is to reduce both bleeding and clotting complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dual antiplatelet therapy (aspirin plus a P2Y12 inhibitor such as clopidogrel or ticagrelor)
What this could lead to
If successful, this could provide a safer, personalized approach to blood thinner use after heart stent procedures, reducing both bleeding and clotting risks.
What could go wrong
This is a large but early-stage algorithm-based study; the score may not outperform standard care, and individual patient factors could still lead to unexpected bleeding or clotting events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Cardiology, Bern University Hospital
RECRUITINGBern, 3010, Switzerland
Contact
-
UOC Cardiologia San Giovanni Addolorata Hospital
RECRUITINGRoma, 00184, Italy
Contact Email: •••••@•••••
-
University Clinical Center of the Republic of Srpska
RECRUITINGBanja Luka, 78000, Bosnia and Herzegovina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact